User:Tori Templin/Sandbox 1
From Proteopedia
(Difference between revisions)
| Line 13: | Line 13: | ||
== Disease == | == Disease == | ||
atherosclerosis, Alzheimer's Disease | atherosclerosis, Alzheimer's Disease | ||
| - | |||
| - | == Relevance == | ||
== Structural highlights == | == Structural highlights == | ||
| Line 20: | Line 18: | ||
<scene name='87/877604/Colored_dimer/2'>Active Dimer</scene> | <scene name='87/877604/Colored_dimer/2'>Active Dimer</scene> | ||
<scene name='87/877604/Practice2/1'>protein orientation</scene> | <scene name='87/877604/Practice2/1'>protein orientation</scene> | ||
| + | |||
| + | == Relevance == | ||
</StructureSection> | </StructureSection> | ||
Revision as of 19:53, 23 March 2021
Acyl-Coenzyme A Cholesterol Acyltransferase
| |||||||||||
References
- ↑ Ransey E, Paredes E, Dey SK, Das SR, Heroux A, Macbeth MR. Crystal structure of the Entamoeba histolytica RNA lariat debranching enzyme EhDbr1 reveals a catalytic Zn(2+) /Mn(2+) heterobinucleation. FEBS Lett. 2017 Jul;591(13):2003-2010. doi: 10.1002/1873-3468.12677. Epub 2017, Jun 14. PMID:28504306 doi:http://dx.doi.org/10.1002/1873-3468.12677
- ↑ Guan C, Niu Y, Chen SC, Kang Y, Wu JX, Nishi K, Chang CCY, Chang TY, Luo T, Chen L. Structural insights into the inhibition mechanism of human sterol O-acyltransferase 1 by a competitive inhibitor. Nat Commun. 2020 May 18;11(1):2478. doi: 10.1038/s41467-020-16288-4. PMID:32424158 doi:http://dx.doi.org/10.1038/s41467-020-16288-4
- ↑ Qian H, Zhao X, Yan R, Yao X, Gao S, Sun X, Du X, Yang H, Wong CCL, Yan N. Structural basis for catalysis and substrate specificity of human ACAT1. Nature. 2020 May;581(7808):333-338. doi: 10.1038/s41586-020-2290-0. Epub 2020 May, 13. PMID:32433614 doi:http://dx.doi.org/10.1038/s41586-020-2290-0
Student Contributors
- Tori Templin
- Haylie Moehlenkamp
- Megan Fleshman
